MyMD Pharmaceuticals Inc (MYMD)

[knuts4oe]

MyMD PHARMA'S PATHS TO SUCCESS

1. MyMD DEVELOPES WORLD'S 1ST 2nd GENERATION TNF-alpha MODULATOR.
2. LAB COMPARISONS OF MYMD-1 WITH 3 POPULAR JAK STAT BLOCKERS FINDS
IT TO BE EQUALLY EFFECTIVE, GIVING IT THE OPPORTUNITY TO GARNER
A PORTION OF THIS MARKET.
3. MyMD EXPECTS TO OFFER ALL HUMANS OVER THE AGE OF 64 THE OPPORTUNITY
TO LIVE LONGER, AND HEALTHIER WHILE DOING SO. IT ALSO SEES THE SAME
BENEFIT TO ALL OTHER MAMMALS WHO REACH COMPARABLE AGES.
4. SOON MyMD WILL BE DOSING PATIENTS DIAGNOSED WITH COVID 19 INDUCED
DEPRESSION, WITH MYMD-1, A POWERFUL ANTI- DEPRESSANT. WHILE IT IS
EXPECTED TO BE EFFECTIVE, IT WILL ALSO DEMONSTRATE IF IT IS EFFECTIVE
AGAINST COVID-19 SIDE EFFECTS AND "LONG-HAULER" PROBLEMS.
5. ON AUG. 10, 2021 MyMD ANNOUNCED RECEIPT OF PATENT # 11,096,933
COVERING ITS SYNTHETIC CBD MOLECULE.
6. IF ALL ABOVE WAS NOT ENOUGH, ON AUG. 10, 2021 MyMD ANNOUNCED ITS
OWNERSHIP OF 13% OF THE STOCK OF ORAVAX MEDICAL, A COMPANY WHICH
HAS BEGUN THE 1ST TEST OF A COVID-19 VACCINE IN PILL FORM.